Updates are available Correction dated 2025-09-09
Click to view Correction: https://doi.org/10.1007/s11060-025-05203-w
-
Authors
Akutagawa, Kazuki
Miki, Shunichiro
Yamada, Erika
Sakamoto, Noriaki
Miyazaki, Tsubasa
Sugii, Narushi
Zaboronok, Alexander
Matsuda, Masahide
Ishikawa, Eiichi
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Scientific Research in Japan (24K02554)
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 29 May 2025
First Online: 12 June 2025
Change Date: 9 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11060-025-05203-w
Declarations
:
: A portion of this work was presented as an oral presentation at the 83rd Annual Meeting of the Japan Neurosurgical Society and the 42nd Annual Meeting of the Japan Society for Neuro-Oncology in 2024.
: The AFTV material described in this paper was provided by Cell-Medicine, Inc. (CMI), a venture company for research and development of immunotherapy established by the initiative of RIKEN (The Institute of Physical and Chemical Research) and the University of Tsukuba in Japan. The authors declare that only T.M. is a member of CMI, and other authors have no conflicts of interest regarding this study.
